Delivery Order SPE2DR25D9239-SPE2DR26FFBV9
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,020.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cerdelga 84 mg capsules (14-count units). The delivery order, issued on October 27, 2025, with completion targeted for November 18, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $32,185.93 for Cerdelga 84 mg capsules (14-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The company was...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $30,046.61, is for the delivery of Cerdelga 84 mg capsules. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $21,891.08 by the Defense Logistics Agency on September 22, 2025, for the supply of Cerdelga 84 mg capsules (quantity: 14 units). This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, carries no set-aside designation and represents work performed under DMS Pharmaceutical Group's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price contract is for the delivery of 4566706859 Cerdelga 84 mg capsules. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $32,185.93, is for the delivery of Cerdelga 84 mg capsules. The contract has an ultimate completion date of July 10, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,185.93 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 84mg capsules of the pharmaceutical product CERDELGA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Cerdelga 84 mg capsules. The $30,046.61 order calls for 14 units of the medication to be delivered to a facility in Park Ridge, Illinois by November 17, 2023. DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract with the Defense Logistics Agency to directly supply prescription medications and services to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,185.93 firm fixed-price delivery order is for the supply of 4565675719 CERDELGA 84 MG CAPSULE 14S, with an ultimate completion date of August 6, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $32,185.93 contract is for the delivery of CERDELGA 84 MG CAPSULE 14S, a pharmaceutical product. The order has an ultimate completion date of August 7, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBV9Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,149.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cerdelga 84 mg capsules. The delivery order, issued on January 9, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, indicating the vendor competed in an unrestricted procurement. This award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499.99 million with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, and medical supplies. DMS Pharmaceutical Group has demonstrated substantial performance as a critical supplier within the federal pharmaceutical supply chain, with numerous delivery orders issued by DLA's Medical Supply Chain division reflecting its capability across diverse therapeutic categories and product lines. The company's established track record in supplying specialized pharmaceuticals—including oncology treatments, immunosuppressants, biologics, vaccines, and emergency medications—positions it as a reliable vendor for recurring medical supply needs of the military healthcare system. The relatively modest value of this particular delivery order for Cerdelga reflects the routine, transactional nature of individual orders issued under the broader PPV-G GEN V framework, which leverages the prime vendor model to ensure efficient, predictable access to critical pharmaceutical products across the global military medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 1/8/26 |